Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Feedback Medical appoints Dr Tom Oakley as CEO

14 Feb 2019 07:00

RNS Number : 9533P
Feedback PLC
14 February 2019
 

Feedback plc

 

Feedback Medical appoints radiologist and NHS England Clinical Entrepreneur Fellow

as CEO

 

Cambridge, UK, 14 February 2019 - Feedback plc (AIM: FDBK, "Feedback", or the "Company"), the specialist medical imaging technology company, announces that its operating subsidiary, Feedback Medical Ltd, has appointed Dr Tom Oakley as its Chief Executive Officer.

 

A qualified clinical radiologist, Dr Oakley has significant experience of successfully launching healthcare products and helping small companies to realise and grow their market potential. This includes serving as Director of NHS services at Synergix Health, where he led the launch of telemedicine services to 40,000 patients. He also founded Innovation Doctor Ltd, a vehicle to explore the digital healthcare space, through which he has supported a number of digital start-ups and SMEs. As Medical Director of 3D LifePrints, a medical 3D printing company, he helped expand their services into 20 NHS trusts whilst also securing growth capital for the business.

 

Dr Oakley also has significant clinical and academic experience, having been an Academic Doctor in Oxford and an Editorial Board Member of the European Medical Journal publication, Innovation. Since 2016, he has been an NHS England Clinical Entrepreneur Fellow, a role awarded to clinicians with a track record of entrepreneurial activity, in order to help them innovate within the NHS by building networks with key healthcare decision makers.

 

Dr Oakley received his Bachelor of Medicine with distinction from the University of Southampton, where he also intercalated with a BSc in Biomedical Sciences. He will report directly to the board of Feedback plc. Dr Alastair Riddell will continue in his role as Executive Chairman of Feedback plc.

 

Tom Oakley, CEO of Feedback Medical, said:

 

"I am joining Feedback Medical at a key time for the company. It has great potential in a market poised for strong growth, with its innovative TexRAD® and Cadran products. I am keen to help the company consolidate its market position, identify growth areas and capture the emerging market segment within digital imaging."

 

Alastair Riddell, Executive Chairman of Feedback plc, said:

 

"Tom's proven track record in leading and developing innovative medical products, and his deep understanding of the NHS will be essential in driving growth for both TexRAD® and Cadran. His combination of clinical knowledge and understanding of market access will be valuable as Feedback Medical grows towards its potential as a leader within the digital imaging sector."

 

 

- ENDS -

 

 

Enquiries:

 

Feedback plc

Alastair Riddell, Executive Chairman

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Instinctif Partners

Rozi Morris / Deborah Bell / Phillip Marriage

+44 (0)20 7457 2020

feedbackplc@instinctif.com

About Feedback plc

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS).

 

For more information, see www.fbkmed.com/plc-landing-page

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGGUGCPUPBPUW
Date   Source Headline
25th Mar 20247:00 amRNSNew tuberculosis partnership in India
21st Mar 20247:00 amRNSFurther CDC Pilot Programme Secured
23rd Feb 202411:03 amRNSHolding(s) in Company
21st Feb 20247:00 amRNSHalf-year Report
21st Feb 20247:00 amRNSMedical Imaging Partnership Pilot Agreement
6th Feb 20247:00 amRNSNotice of Results & Investor Presentation
19th Dec 20237:01 amRNSHalf Year Trading Update
19th Dec 20237:00 amRNSAward of Pilot Funding
26th Oct 20232:24 pmRNSResult of AGM
25th Oct 20235:53 pmRNSDirector Dealing
27th Sep 202312:15 pmRNSNotice of AGM
12th Sep 20237:00 amRNSFinal Results
5th Sep 20237:00 amRNSNotice of Results & Investor Presentation
19th Jun 20237:00 amRNSYear End Trading Update
4th Apr 20237:00 amRNSBleepa-CareLocker contract extension with QVH
7th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:56 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSNotice of Results, Analyst & Investor Presentation
22nd Dec 202212:08 pmRNSDirector/PDMR Shareholding: Correction
22nd Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSHalf Year Trading Update
1st Nov 20223:36 pmRNSTotal Voting Rights
13th Oct 20222:55 pmRNSResult of AGM & Proposed Share Consolidation
29th Sep 20223:46 pmRNSHolding(s) in Company
20th Sep 20223:26 pmRNSNotice of AGM & Proposed Share Consolidation
20th Sep 20227:00 amRNSFinal Results
13th Sep 20227:00 amRNSNotice of Results & Investor Presentation
6th Sep 20227:00 amRNS12 month contract for Sussex CDC pilot extension
19th Jul 20227:00 amRNSContract Update
16th Jun 20227:00 amRNSYear End Trading Update
1st Jun 20227:00 amRNSTrading Update & Director Appointment
12th May 202212:44 pmRNSChange of Registered Office
12th Apr 20227:00 amRNSBleepa wins two NHS Contract Awards
31st Mar 20227:00 amRNSBleepa TB Screening Pilot Now Live in Odisha
23rd Feb 20227:00 amRNSGrant of Options and PDMR dealing
10th Feb 20227:00 amRNSInterim Results
31st Jan 20227:00 amRNSNotice of Results
13th Dec 20217:00 amRNSPartnership with Amazon Web Services
6th Dec 20213:06 pmRNSHolding(s) in Company
2nd Dec 202110:20 amRNSDirector/PDMR Shareholding
2nd Dec 20219:54 amRNSHolding(s) in Company
1st Dec 20214:27 pmRNSHolding(s) in Company
1st Dec 20213:09 pmRNSHolding(s) in Company
30th Nov 20214:05 pmRNSHolding(s) in Company
29th Nov 20211:36 pmRNSDirector Appointment
29th Nov 20211:35 pmRNSResults of AGM, Open Offer, Issue of Equity & TVR
18th Nov 202112:15 pmRNSHolding(s) in Company
16th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20211:52 pmRNSResult of Placing
2nd Nov 20217:01 amRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.